Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-134P (RNA, U1 small nuclear 134, pseudogene) is a human pseudogene located on chromosome 20 (20q13). It is assigned as one of many non-coding pseudogenes in the genome related to the U1 small nuclear RNA (snRNA) gene family. Unlike canonical U1 snRNA genes (such as RNU1-1), RNU1-134P is not known to produce a functional RNA product or contribute to the spliceosomal machinery essential for pre-mRNA splicing. Pseudogenes of this class typically arise through DNA or RNA-mediated duplication and acquire disabling mutations that prevent expression of the canonical RNA. While some U1 snRNA pseudogenes or their processed RNA products have shown low-level expression or potential regulatory roles in certain contexts, there is no evidence that RNU1-134P is functional or plays a role in disease, regulation, or therapy. It is classified primarily as part of the genomic background and is not used as a therapeutic target or biomarker.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 134, pseudogene (RNU1-134P).